Machine Learning Approach Accelerates Discovery of Novel CDK9 Inhibitors
Machine Learning Approach Accelerates Discovery of Novel CDK9 Inhibitors
Publish Date: 2026-01-15 10:33:00
Source Domain: ascopost.com
- A virtual screening campaign utilizing machine learning and artificial intelligence identified 14 potential novel CDK9 inhibitors for cancer treatment.
- AI integration accelerated the analysis and identification process, significantly reducing time and cost in the early drug discovery phase.
- Among the 14 candidates, one molecule showed high inhibitory activity in tests with cervical carcinoma and breast cancer cellular models as well as in three different cancer cell lines.
- The selected compound demonstrated cytotoxic effects both alone and in combination with camptothecin, indicating its promise as a therapeutic agent.
- Researchers emphasize the vital role of AI in the identification of new molecules for cancer treatment, while underscoring the necessity of experimental validation by human scientists.
